Keep up with our news and events

News

Azitra Appoints Francisco Salva as Chief Executive Officer

Ginkgo Bioworks, Azitra, Florida International University, and Latham BioPharm Group Awarded $15M by DARPA to Develop Skin Microbiome-based Mosquito Repellent

Leaps by Bayer leads USD 17 million Series B financing in biotech company Azitra

Azitra to Present at the Upcoming 2020 Summer Private Company Showcase

Summer 2020 NYC Private Company Showcase

Azitra Awarded U.S. Composition of Matter Patent Covering Engineered Bacterial Strains for Treating Skin Conditions

Medical dermatology company Azitra relocates to Branford

Azitra Announces Relocation to New Facility

Azitra Announces Rare Pediatric Disease Designation for ATR-12 for the Treatment of Netherton Syndrome

Azitra Taps Microbiome For Dermatology Therapies, Including Cancer Supportive Care

Bayer and Azitra partner to harness the human skin microbiome as a source for new natural skin care products for sensitive and eczema-prone skin

The Azitra approach: Treating disease targets with microbial darts

Skin & the Microbiome – Richard Andrews, President/CEO and Mark Sampson, Chief Scientific Officer, of Azitra

Azitra Names Jeanne M. Bertonis as Chief Operating Officer

Azitra Completes $14 Million Series A Financing

Azitra Presents Data Showing Tolerability of its Lead Product Candidate ATR-04

Azitra, Inc. Appoints Mark Sampson, Ph.D. as Chief Scientific Officer

Azitra, Inc. Expands Research and Development Team to Support Clinical Development Program

Azitra Receives Ongoing Support for its Netherton Development Program from the National Science Foundation (NSF)

Azitra Demonstrates Feasibility of Engineering the Skin Microbiome to Treat Serious Skin Conditions

Chardan’s 1st Annual Microbiome Summit

Azitra featured as “Company to Watch” by Life Science Leader

Azitra’s Clinical Study of ATR-04 for Cosmetic Use Completes Enrollment

Pharmabiotics Conference 

North American Microbiome Congress

Microbiome Drug Development Summit Europe

Azitra to Present at the Biotech Showcase™ Annual Conference on January 7, 2019

Azitra to Present at the Biotech Showcase™ Annual Conference on January 7, 2019

European Skin Microbiome Congress

Azitra and Jackson Labs Receive Department of Defense Grant for Next-Generation Anti-Infectives

Azitra Awarded NIH SBIR Grant to Develop Microbiome-based Therapeutic for Netherton Syndrome

Cosmetics & Toiletries

Azitra Secures $2.15 Million Convertible Debt Financing Led Jointly by Bios Partners and Connecticut Innovations

Azitra to Present at the Biotech Showcase™ Annual Conference on January 8, 2018

Azitra Founder Travis Whitfill, MPH named Forbes “30 under 30 in Healthcare”

Richard Andrews Appointed CEO

Julia Oh, Ph.D., Multi-Award winner

Azitra Raises $3.75 Million

Top